"TBSF" (20%) Human Albumin Solution

Krajina: Austrália

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktívna zložka:

Albumin, Quantity: 200 g/L

Dostupné z:

CSL Behring Australia Pty Ltd

INN (Medzinárodný Name):

Albumin

Forma lieku:

Injection, solution

Zloženie:

Excipient Ingredients: octanoate; sodium

Spôsob podávania:

Intravenous

Počet v balení:

50mL, 100mL

Trieda:

Medicine Listed (Export Only)

Typ predpisu:

(S1) This Schedule is intentionally blank

Terapeutické indikácie:

Hypoproteinaemia in the acutely ill patient TBSF (20%) Human Albumin Solution is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. Shock. TBSF (20%) Human Albumin Solution may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4 - 5% human albumin is preferred when available. Burns. Extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins resulting in hypovolaemic shock and circulatory failure.

Prehľad produktov:

Visual Identification: Clear, slightly viscous almost colourless, yellow or green; Container Type: Vial; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius

Stav Autorizácia:

Listed (Export Only)

Dátum Autorizácia:

2006-03-01